EUVIMEDOpdag EUVIMED
Vergleichsstudie

Outcomes of LAAO vs. DOACs in Obese Patients With Atrial Fibrillation a 5‐Year Propensity‐Matched Analysis

Mohamad Mdaihly iD, Issam Motairek, Arwa Younis, Chadi Tabaja, Joe Demian iD, Adele Watfa iD, Besir Besir, Ayman A Hussein, Tyler Taigen, Mandeep Bhargava, Mohamed Kanj, Bryan Baranowski and 5 more

Pacing and Clinical Electrophysiology · 2026

DOI: 10.1111/pace.70089 ↗

At a glance

Vergleichsstudie in Pacing and Clinical Electrophysiology, 2026. Written by Mohamad Mdaihly and 16 co-authors. Institution: Department of Cardiovascular Medicine, Cleveland Clinic, Cardiac Electrophysiology and Pacing Section, Cleveland, Ohio, USA. Major MEDLINE topics: Atrial Fibrillation, Obesity, Atrial Appendage, Anticoagulants. 32 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Obese patients with atrial fibrillation (AF) are at an increased risk of thromboembolic and bleeding events. While direct oral anticoagulants (DOACs) are the standard therapy for stroke prevention in AF, their use is associated with a significant bleeding risk in this population. Comparative data of left appendage atrial occlusion (LAAO) vs. DOACs in this group are currently lacking.

Objective

To compare the 5‐year clinical outcomes of LAAO vs. DOACs in obese patients with AF.

Methods

Data were extracted from the TriNetX database, identifying obese patients with AF (BMI ≥40 kg/m 2 ). Two cohorts were defined: those undergoing LAAO ( n = 1571) and those treated with DOACs ( n = 103,047). Propensity score matching was conducted to adjust for demographics, comorbidities, and stroke/bleeding risk scores, resulting in matched cohorts of 1566 patients each. Outcomes assessed included ischemic stroke, non‐traumatic intracranial hemorrhage, major bleeding, MI, and all‐cause mortality. Kaplan–Meier survival curves and hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated for group comparisons.

Results

At 5 years, stroke rates were similar between LAAO and DOAC groups (HR:1.00; 95% CI: 0.69–1.43; p = 0.984), as were major bleeding rates similar (HR:0.99; 95% CI: 0.71–1.42; p = 0.969). MI risk was comparable between the groups (HR:1.05; 95% CI: 0.66–1.36; p = 0.772). Importantly, LAAO was associated with lower all‐cause mortality (HR:0.64; 95% CI: 0.54–0.76; p < 0.001).

Conclusions

In obese patients with AF, LAAO offers a comparable stroke and bleeding protection to DOACs, while reducing all‐cause mortality over 5 years. These findings underscore the potential of LAAO as a long‐term strategy for stroke prevention in this high‐risk population.

Subjects

MeSH terms (MEDLINE)

Atrial FibrillationObesityAtrial AppendageAnticoagulantsHumansMaleFemaleAgedPropensity ScoreStrokeHemorrhageMiddle AgedTreatment OutcomeAdministration, OralRetrospective Studies

Author keywords

atrial fibrillationdirect oral anticoagulants (DOACS)left atrial appendage occlusion (LAAO)obesitystroke prevention

Substances

Anticoagulants

Authors and institutions

  • Department of Cardiovascular Medicine, Cleveland Clinic, Cardiac Electrophysiology and Pacing Section, Cleveland, Ohio, USA.

ORCID profiles: Mohamad Mdaihly, Joe Demian, Adele Watfa

Cite

APA

Mdaihly, M., Motairek, I., Younis, A., Tabaja, C., Demian, J., Watfa, A., Besir, B., Hussein, A. A., Taigen, T., Bhargava, M., Kanj, M., Baranowski, B., Jaber, W., Santangeli, P., Chung, M., Saliba, W. I., & Wazni, O. M. (2026). Outcomes of LAAO vs. DOACs in Obese Patients With Atrial Fibrillation a 5‐Year Propensity‐Matched Analysis. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70089

Vancouver

Mdaihly M, Motairek I, Younis A, Tabaja C, Demian J, Watfa A, et al. Outcomes of LAAO vs. DOACs in Obese Patients With Atrial Fibrillation a 5‐Year Propensity‐Matched Analysis. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70089

BibTeX
@article{Mdaihly2026,
  author = {Mdaihly, Mohamad and Motairek, Issam and Younis, Arwa and Tabaja, Chadi and Demian, Joe and Watfa, Adele and Besir, Besir and Hussein, Ayman A and Taigen, Tyler and Bhargava, Mandeep and Kanj, Mohamed and Baranowski, Bryan and Jaber, Wael and Santangeli, Pasquale and Chung, Mina and Saliba, Walid I and Wazni, Oussama M},
  title = {Outcomes of LAAO vs. DOACs in Obese Patients With Atrial Fibrillation a 5‐Year Propensity‐Matched Analysis},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2026},
  doi = {10.1111/pace.70089}
}
Start for free →